TechNavio Announces the Publication of its Report - Global HIV
Drugs Market 2010-2014
TechNavio today launched its Global HIV Drugs Market 2010-2014 report based on an indepth study focusing on the Americas and the EMEA and APAC regions.
London, UK,...
More
TechNavio Announces the Publication of its Report - Global HIV
Drugs Market 2010-2014
TechNavio today launched its Global HIV Drugs Market 2010-2014 report based on an indepth study focusing on the Americas and the EMEA and APAC regions.
London, UK, December 21, 2011 -- TechNavio today launched its Global HIV Drugs Market 20102014 report based on an in-depth study focusing on the Americas and the EMEA and APAC regions.
The report aids decision makers’ understanding of the key trends impacting the growth of this
market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said, “Major issues such
as resistance to ART, patent expirations, and increasing HIV infections have created a need for
novel drugs.
The trend is moving towards development of new ART drugs that operate outside
infected cells.
This could include new class of drugs for entry inhibitors, coreceptor antagonists and
fusion inhibitors.
”
According to the report, early initiation of Highly Active AntiR
Less